Apricot Forest
Apricot Forest's mobile app provides doctors with patient records
About Apricot Forest
Apricot Forest, known as Xingshulin in China, was established in 2011 by Dr. Yusheng Zhang. The company's name is inspired by the ancient Chinese fable of Dong Feng, a skilled doctor from the Three Kingdoms period who, instead of charging fees, asked cured patients to plant apricot trees, eventually creating a forest that benefited the entire community. Dr. Zhang, motivated by his own experiences and the desire to bridge the medical and tech worlds, aimed to address the systemic inefficiencies and immense pressure faced by physicians in China.
The company operates in China's digital healthcare market, providing mobile software and services specifically for physicians. It targets the core challenges of an overburdened healthcare system where doctors often manage caseloads of 50 to 60 patients daily. Apricot Forest's business model is multifaceted, generating revenue by charging pharmaceutical companies for advertising within its apps, taking a percentage from the sales of medical literature and books, and planning to charge patients for premium follow-up consultations with their doctors.
Apricot Forest offers a suite of three applications designed to streamline physicians' workflows. The primary app, MedClip, functions as a comprehensive patient management system, allowing doctors to digitally store and organize patient records, dictate notes, communicate with patients via messaging platforms like WeChat, and consult with peers on complex cases. A second app, e-Pocket, serves as a digital reference tool containing drug formularies and medical calculators. The third, Medical Journals, enables doctors to stay current with the latest research. These tools aim to improve care quality and make the medical practice more efficient for China's doctors.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Dongcheng District, China
- Open positions
- 1
- Dealroom signal
- 21.3/100
- Industry
- Health, Telecom
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Jan 2016 | $30M | $120M | BlueRun Ventures · Joincare Pharmaceutical | — |
| SERIES CEquity / VC | Dec 2014 | $8.9M | $36M | Undisclosed | — |
Growth signals
Latest recorded traffic for Apricot Forest is 19K monthly website visits, down 24% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Joincare Pharmaceutical
BlueRun Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Apricot Forest on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Apricot Forest’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







